Related Experiment Video
Updated: Dec 23, 2025
11:29
Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
Published on: June 20, 2020
9.6K
Evaluation of user embracement software with pediatric risk classification
Gilvan Ferreira Felipe1, Francisca Elisangela Teixeira Lima2, Lorena Pinheiro Barbosa2
1Universidade da Integração Internacional da Lusofonia Afro-Brasileira. Redenção, Ceará, Brazil.
Revista Brasileira De Enfermagem
|April 23, 2020
Summary
This study found user embracement software for pediatric risk classification to be technically sound and functionally adequate. Both informatics and nursing specialists confirmed its high performance and quality.
Area of Science:
- Health Informatics
- Software Engineering
- Pediatric Nursing
Background:
- Effective software is crucial for pediatric risk classification.
- Evaluating software quality ensures user embracement and reliable performance.
Purpose of the Study:
- To assess the functional performance and technical quality of user embracement software.
- To evaluate software used in pediatric risk classification.
Main Methods:
- A descriptive exploratory study using ISO/IEC 25010 quality requirements.
- Eight informatics and 13 nursing specialists evaluated functional adequacy, reliability, usability, performance efficiency, compatibility, safety, maintainability, and portability.
- Adequacy was defined as >70% of specialists rating characteristics as very/completely appropriate.
Main Results:
- Software achieved high scores in all evaluated characteristics by both specialist groups.
- Functional adequacy was rated 100% by informatics and 96.2% by nursing specialists.
- Usability, safety, and performance efficiency exceeded 90% approval from both groups.
Conclusions:
- The software demonstrates adequate technical quality and functional performance for pediatric risk classification.
- Specialist evaluations confirm the software's suitability for its intended application.
- High ratings across all ISO/IEC 25010 characteristics indicate robust software design.
Related Concept Videos
01:18Guidelines and Strategies for Safe Computer Charting
2.6K
The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Maintain Confidentiality and Security:
2.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
334
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
334
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
174
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174
01:29Drug Dosing: Infants and Children
177
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
177
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
149
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
149